Skip to content
HOME
TEAM
RESEARCH
Unveiling the role of gut microbiota and microbial metabolites in MASLD pathogenesis
Gut microbiota and MASH/fibrosis resolution after bariatric surgery
Evaluation of the epigenome microbiome and metabolome dynamics and their interaction with the adiposity increase in the maternal-infant axis
Epitranscriptomic analysis in patients with MASLD/MASH: exploring diagnostic and therapeutic potential
Role of small intestine in type 2 diabetes mellitus and search for new therapeutic strategies
Diagnostic and therapeutic potential of polyamine metabolism in MASLD
PROJECTS
PUBLICATIONS
NEWS
CONTACT
HOME
TEAM
RESEARCH
Unveiling the role of gut microbiota and microbial metabolites in MASLD pathogenesis
Gut microbiota and MASH/fibrosis resolution after bariatric surgery
Evaluation of the epigenome microbiome and metabolome dynamics and their interaction with the adiposity increase in the maternal-infant axis
Epitranscriptomic analysis in patients with MASLD/MASH: exploring diagnostic and therapeutic potential
Role of small intestine in type 2 diabetes mellitus and search for new therapeutic strategies
Diagnostic and therapeutic potential of polyamine metabolism in MASLD
PROJECTS
PUBLICATIONS
NEWS
CONTACT
Loading...
RESEARCH
RESEARCH
MetaObesity Lab
2021-09-10T19:09:34+02:00
Research Lines
OUR LABORATORY IS CURRENTLY WORKING ON 3 MAIN ACTIVE RESEARCH LINES.
Unveiling the role of gut microbiota and epigenetic alterations in the pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Gut microbiota and related metabolites as potential markers of non-alcoholic steatohepatitis (NASH) resolution after bariatric surgery
Gut microbiome modification through dietary intervention in patients with colorectal cancer (CRC) and response to surgery
Page load link
Go to Top